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Causes of congenital corneal opacities and
their management in a tertiary care center
Causas de opacidades corneanas congênitas e seu controle
em um centro de cuidados terciários
Remzi Karadag1,2

, Christopher J. Rapuano2, Kristin M. Hammersmith2, Parveen K. Nagra2

1. Department of Ophthalmology, School of Medicine, Istanbul Medeniyet University, Istanbul, Turkey.
2. Cornea Service, Wills Eye Hospital, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, USA.

ABSTRACT | Purpose: To evaluate causes and management of
congenital corneal opacities (CCO) diagnosed in a tertiary care
eye center and to compare the data with a previous study at the
same institution. Methods: Computerized medical records in
all patients with congenital corneal opacities diagnosed in the
Cornea Service at Wills Eye Hospital (Philadelphia, PA) between
January 1, 2007, and December 31, 2015, were retrospectively
reviewed. Children aged 12 years and younger at the first visit
were included in the study. Patients’ demographics, ocular
diagnosis, laterality, associated ocular abnormalities, other
ocular surgery performed prior or subsequent to the first visit,
and their treatment were extracted from the medical records.
Results: A total of 77 eyes in 56 patients were examined. The
mean age at presentation was 32.8 ± 44.2 months, with the
mean follow-up period of 26.7 ± 30.1 months. The most frequent diagnosis was Peters anomaly (53.2%), followed by limbal
dermoid (13.0%), aniridia with glaucoma and microphthalmos
(6.5%), sclerocornea and congenital glaucoma (5.2%), idiopathic
(3.9%), Axenfeld-Rieger anomaly and Hurler syndrome (2.6%),
and microcornea (1.3%). Primary keratoplasty was performed
in 26 eyes, with the outcome rate in the clear cornea of 76.0%
during the follow-up. Conclusion: Peters anomaly is the most
common cause of congenital corneal opacities encountered at
our institution. Penetrating keratoplasty is the most frequent
choice of corneal surgery to treat congenital corneal opacities.
Additional interventions during penetrating keratoplasty were
moderately positively correlated with graft failure. This study
also shows the rates of some etiologies of that changed over the
recent decades in our tertiary care Cornea Service. Although
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Peters anomaly remains the most common presenting reason for
congenital corneal opacities, its rate appears to be increasing
over the recent decade. Congenital corneal opacities due to birth
trauma, which is one of the preventable causes, were observed
in a previous study in our clinic; however, no new cases were
noted in this study.
Keywords: Cornea/abnormalites; Corneal opacity/congenital;
Keratoplasty, penetrating; Peters anomaly; Tertiary healthcare
RESUMO | Objetivo: Avaliar as causas e o controle das opa
cidades corneanas congênitas diagnosticadas em um centro
oftalmológico de atendimento terciário e comparar os dados com
um estudo anterior realizado na mesma instituição. Métodos:
Prontuários médicos informatizados de todos os pacientes com
opacidade corneana congênita diagnosticada no Serviço
de Córnea no Wills Eye Hospital (Filadélfia, PA) entre 1º de
janeiro de 2007 e 31 de dezembro de 2015 foram revisados
retrospectivamente. Crianças com 12 anos ou menos na primeira
consulta foram incluídas no estudo. A demografia dos pacientes,
o diagnóstico ocular, a lateralidade, as anormalidades oculares
associadas, outras cirurgias oculares realizadas antes ou após a
primeira consulta e o tratamento foram extraídos dos prontuários
médicos. Resultados: Um total de 77 olhos de 56 pacientes foi
examinado. A idade média de apresentação foi de 32,8 ± 44,2
meses, com um tempo médio de acompanhamento de 26,7
± 30,1 meses. O diagnóstico mais frequente foi anomalia de
Peters (53,2%), seguido por dermóide límbico (13,0%), aniridia
com glaucoma e microftalmia (6,5%), esclerocórnea e glaucoma
congênito (5,2%), idiopático (3,9%), síndrome de Axenfeld-Rieger
e síndrome de Hurler (2,6%) e microcórnea (1,3%). Ceratoplastia
primária foi realizada em 26 olhos, com desfecho de córnea clara
de 76,0% durante o acompanhamento. Conclusão: A anomalia
de Peters é a causa mais comum de opacidade corneana congênita
encontrada em nossa instituição. A ceratoplastia penetrante é a
escolha mais frequente de cirurgia corneana para o tratamento
de opacidades corneanas congênitas. Intervenções adicionais
durante a ceratoplastia penetrante foram moderadamente
correlacionadas positivamente com a falha do enxerto. Este
estudo também mostra as taxas de algumas etiologias do que
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mudou ao longo faz últimas décadas em nosso serviço de córnea
de atendimento terciário. Embora a anomalia de Peters continue
a ser a causa mais comum das opacidades congênitas da córnea,
sua taxa parece estar aumentando na última década. Opacidades
congênitas da córnea devido a trauma no nascimento, que é uma
das causas evitáveis, foram observadas em um estudo anterior
em nossa clínica; no entanto, nenhum caso novo foi observado
neste estudo.
Descritores: Córnea/anormalidades; Opacidade da córnea/
congênito; Ceratoplastia penetrante; Atenção terciária à saúde

INTRODUCTION
Congenital corneal opacities (CCO) are defined as a
group of diseases characterized by loss of transparency
in the corneal tissue at birth or during the first 4 weeks
of life(1,2). Etiologic factors affecting the anterior segment differentiation between the 6th and 16th weeks of
gestation are responsible for most CCOs. These factors
may be infectious, genetic, metabolic, developmental,
traumatic, toxic, idiopathic, or a combination of these(1,2).
Most cases are bilateral and are often observed with other
ocular malformations. They may also be accompanied by
complex systemic disorders. CCO incidence is reported
from 2.2 to 3.11 per 100,000 births(3-5). Although CCO
is a rare entity, prompt diagnosis and treatment are very
important due to the high risk of amblyopia and possibility of lifelong visual impairment in bilateral cases(3,4).
Its diagnosis, treatment, and follow-up were associated
with their own set of difficulties(1-4).
This study aimed to analyze the data (patients’ demographics, ocular diagnosis, laterality, associated ocular
abnormalities, other ocular surgery performed prior or
subsequent to the first visit, and the treatment) of CCO
children diagnosed in the Cornea Service at Wills Eye
Hospital between January 2007 and December 2015 and
compare the results with another study also conducted
in our Service a decade prior as well as other studies in
the literature.
METHODS
Computerized medical records of all patients with
CCO diagnosed in the Cornea Service at Wills Eye Hospital (Philadelphia, PA) between January 1, 2007, and
December 31, 2015, were retrospectively reviewed. Patients were identified through a computerized diagnosis
code search. Children aged 12 years and younger at their
first visit to our Cornea Service were included in the
study. Patients with eyes that underwent previous cor-

neal surgery in another hospital were excluded. Patients’
de
mographics, ocular diagnosis, laterality, associated
ocular abnormalities, other ocular surgeries performed
prior or subsequent to the first visit, and the treatment
and surgical outcomes were extracted from medical
records. This study protocol was approved by the Wills
Eye Hospital Institutional Review Board and conducted
in accordance with the Declaration of Helsinki.
The SPSS software version 16 (SPSS Inc., Chicago,
IL, USA) were used for statistical analyses. The Kolmogorov-Smirnov test was used to investigate variables in
order to determine whether or not they are normally
distributed. Descriptive statistical methods (mean, standard deviation, median, frequency, ratio, minimum, and
maximum) were used to evaluate this study’s data. The
Spearman’s correlation test was used to evaluate the
data. P-values of <0.05 were considered statistically
significant.
RESULTS
A total of 96 eyes in 64 patients (32 unilateral, 32
bilateral) with CCO were identified from the medical
records. After excluding 19 eyes that had corneal
surgery prior to the first visit at Wills, 77 eyes in 56
patients were included in the analysis. Among them, 30
(53.6%) were females and 26 (46.4%) were males. Both
eyes were diagnosed with CCO in 21 patients (38%).
The mean age at presentation was 32.9 ± 44.2 (range,
0.2-144) months, with the mean follow-up period of
26.7 ± 30.1 (range 0.1-103) months. The most frequent
diagnosis was Peters anomaly (41 eyes, 53.2%), followed by limbal dermoid (13.0%), aniridia with glaucoma
(6.5%), microphthalmos (6.5%), sclerocornea (5.2%),
congenital glaucoma (5.2%), idiopathic corneal opacity
(3.9%), Axenfeld-Rieger anomaly (2.6%), Hurler syndrome (2.6%), and microcornea (1.3%) (Table 1). Corneal
findings in all eyes at presentation are presented in table 2.
Corneal findings in eyes with Peters anomaly are shown
in table 3. The most common findings were central haze/
scar (27 eyes, 65.9%), paracentral haze/scar (12.2%),
edema (9.7%), and pannus (9.7%). Thirty eyes (39.0%)
underwent corneal surgery, which included penetrating
keratoplasty in 25 eyes (32.5%), limbal dermoid excision
in 3 (3.9%), keratoprosthesis in 1 (1.3%), and lamellar
keratectomy in 1 (1.3%) (Table 4).
Patients’ diagnoses are summarized in table 5.
Ocular surgery, other than corneal surgery, was
performed in 16 eyes prior to the first visit at Wills.
Arq Bras Oftalmol. 2020;83(2):98-102
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Table 1. Diagnosis for congenital corneal opacity
Diagnosis

Number of eyes

%

Peters anomaly

41

53.2

Limbal dermoid

10

13.0

Aniridia with glaucoma

5

6.5

Microphthalmos

5

6.5

Sclerocornea

4

5.2

Congenital glaucoma

4

5.2

Idiopathic corneal opacity

3

3.9

Axenfeld-Rieger Anomaly

2

2.6

Hurler syndrome

2

2.6

Microcornea

1

1.3

Table 2. Presenting timely corneal findings
Corneal findings

Number of eyes

%

Central haze/scar

37

48,1

Diffuse full thickness haze

13

16.9

Corneal mass

9

11.7

Neovascularization/pannus

11

14.3

Paracentral/peripheral haze/scar

12

15.6

Edema

8

10.4

Microcornea

5

6.5

Band keratopathy

4

5.2

Scleralization

4

5.2

Buphthalmos

5

6.5

Posterior embryotoxon

5

6.5

Posterior keratoconus

1

1.3

*More than one finding may occur in the same eye.

Table 4. Surgeries performed prior to presentation, corneal surgeries
performed at our institution, and concurrent and subsequent surgeries
to the corneal surgeries.
Number of eyes*

%

Glaucoma drainage device

4

5.2

Trabeculectomy

4

5.2

Trabeculotomy/goniotomy

2

2.6

Cataract extraction

4

5.2

Phacoemulsification with lens implant

3

3.9

Cyclophotocoagulation

3

3.6

Strabismus surgery

2

2.6

Penetrating keratoplasty

25

32.5

Lamellar keratectomy

1

1.3

Primary keratoprosthesis

1

1.3

Limbal dermoid excision

3

3.9

Second penetrating keratoplasty

5

6.5

Keratoprosthesis after penetrating keratoplasty

1

1.3

Third penetrating keratoplasty

2

2.6

Fourth penetrating keratoplasty

1

1.3

Lensectomy

7

9.1

Anterior vitrectomy

7

9.1

Peripheral iridectomy

12

15.6

Release of synechiae

7

9.1

Cyclophotocoagulation

2

2.6

Amniotic membrane transplantation

2

2.6

Pars plana vitrectomy

1

1.3

Laser retinopexy

1

1.3

Glaucoma drainage device

2

2.6

Cataract extraction

2

2.6

Strabismus surgery

3

3.9

Prior to time of presentation

Corneal surgery

Concurrent surgery to corneal surgery

Subsequent or additional surgery to corneal surgery

Table 3. Corneal findings in 41 eyes with Peters anomaly

Pupilloplasty

2

2.6

Corneal findings

Number of eyes (n)

%

Phacoemulsification with lens implant

2

2.6

Central haze/scar

27

65.9

Revision of glaucoma drainage device

1

1.3

Paracentral haze/scar

5

12.2

Edema

4

9.7

Pannus

4

9.7

Posterior embryotoxon

3

7.3

Band keratopathy

3

7.3

Neovascularization

3

7.3

Diffuse full thickness haze

3

7.3

Diagnosis

Eyes (n)

%

Peripheral haze/scar

2

4.9

Peters anomaly

20

76.9

Indistinct limbus

2

4.9

Aniridia glaucoma

2

7.7

Microcornea

1

2.4

Sclerocornea

2

7.7

2.4

Congenital glaucoma

1

3.8

Idiopathic corneal opacity at birth

1

3.8

Posterior keratoconus

1

*More than one findings may occur in the same eye.
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Table 5. Diagnosing eyes undergoing primary penetrating keratoplasty

Karadag R, et al.

Concurrent surgeries were performed in 15 eyes at the
time of corneal surgery, as shown in table 4. Five of 25
eyes that underwent penetrating keratoplasty underwent
a second keratoplasty, and one eye underwent kerato
prosthesis (four of these six eyes had Peters anomaly
and the other two eyes had sclerocornea) (24% graft
failure). Keratoplasties were performed in three eyes,
and a fourth keratoplasty in one eye. When analyzing
six eyes with graft failure, four had Peters anomaly (20
total eyes had Peters anomaly) and two of them had
sclerocornea (2 total eyes had sclerocornea). The graft
failure rate was 20% in patients with Peters anomaly
and 100% in those with sclerocornea.
Glaucoma was observed in 24 eyes (31.2%) prior to
their first visit or during our follow-up at Wills. Glaucoma surgeries were performed 13 eyes prior to their
first visit including four glaucoma drainage devices, four
trabeculectomies, 3 cyclophotocoagulations, and two tra
beculotomy/goniotomy procedures. Concurrent glaucoma surgeries were performed in two eyes (cyclophotocoagulation) at the time of corneal surgery. Additionally,
subsequent glaucoma surgeries were performed in two
eyes, and revision of a glaucoma drainage device was
performed in one eye after a corneal surgery (Table 4).
Seven of the 24 eyes were followed with medical glaucoma treatment. The correlation between the presence
of glaucoma and history of previous surgery before the
presentation was statistically significantly moderately
positive (r=0.498, p=0.010). Concurrent intervention
at the time of primary keratoplasty was statistically mo
derately correlated with the need for secondary keratoplasty (r=0.445, p=0.026). The outcome rate in the
clear cornea during the follow-up was 76.0%.
DISCUSSION
Patients with CCO are highly at risk of deprivation
amblyopia since a clear cornea is required for healthy
vision development. Furthermore, because these conditions are commonly bilateral, patients are highly at
risk for lifelong visual impairment. Therefore, diagnosis,
determination of concomitant ocular and systemic pathologies, and treatment of CCO as early as possible are
essential(1,2,5).
CCO is an etiologically heterogenic situation. Its
occurrence CCO vary depending on the developmental
level of the country and genetic and environmental factors. Only a few studies investigated these conditions(1-5).
However, most of the information in these studies was
obtained from pediatric keratoplasty. Not surprisingly,

the most common reasons for CCO vary between different countries(1-8).
Peters anomaly is found in 40.3% and 72.7% of patients in two of the largest studies on CCO, the first one
in the USA(1), in the previous study in our institution, and
the second one in Japan(2). Sclerocornea is the second
most common etiology, with the occurrence rate of 18%
in a US study(1) and anterior staphyloma in a Japanese
study(2). In the present study, Peters anomaly (53.2%)
was the most common etiology of CCO, followed by
limbal dermoid (13.0%), aniridia with glaucoma and
mi
crophthalmos (6.5%), sclerocornea and congenital
glaucoma (5.2%), idiopathic (3.9%), and Axenfeld-Rieger
anomaly and Hurler syndrome (2.6%) according to frequency. This study also shows CCO rates that changed
over the recent decades in our tertiary care Cornea Service. In our previous study, the most common primary
cause of CCO was Peters anomaly (40.3%), followed by
sclerocornea (18.1%), dermoid (15.3%), congenital glaucoma and idiopathic (6.9%), microphthalmia (4.2%), and
birth trauma and metabolic diseases (2.8%). Even though
Peters anomaly remains the most common etiology of
CCO, its rate appears to be increasing in the recent
decade. CCO due to birth trauma, which is one of the
preventable causes, was observed in 2.8% of patients
in our clinic’s previous study(1); however, no new case
was detected in this study. Although idiopathic CCO was
observed in 6.9% of the patients in our clinic’s previous
study(1), its rate appears to be decreasing in the recent
decade (3.9%). Bilateral involvement of CCO was observed in 73.6% of patients from the Far East,2 55.3% in our
clinic’s previous study(1), and 54.6% in this study.
In a Saudi Arabian study, Al-Ghamdi et al. reported
130 patients with primary pediatric keratoplasty had
CCO. In their cases, the most common etiologies were
congenital glaucoma (33.7%), congenital hereditary endothelial dystrophy (CHED) (26.9%), and Peters anomaly
(21.5%)(6). In Patel et al.’s study in New Zealand, nine
pediatric keratoplasties were performed over a 13-year
period because of CCO, and 44.7% of them had Peters
anomaly, followed by CHED (22.2%), idiopathic (22.2%),
and limbal dermoid (11.1%)(7). In a Finland study, Majander et al. evaluated 14 eyes of seven patients with
CCO who underwent anterior segment optic coherence
tomography. Peters anomaly with the rate of 71.4%,
congenital corneal staphyloma with 21.4%, and microphthalmos with 7.1% were diagnosed in these eyes(8).
Because the risk of amblyopia and visual impairment
is high in eyes with CCO, keratoplasty, most frequently
penetrating keratoplasty, is the most common treatment
Arq Bras Oftalmol. 2020;83(2):98-102
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method(7-10). Penetrating keratoplasty is an especially
risky procedure in children because their ocular tissues
continuously grow, scleral flexibility is high, follow up
is more difficult, and other ocular pathologies are commonly present in this age group(8,9). In our study, primary
penetrating keratoplasty was the most common procedure with a rate of 32.5%, which was similar with our
clinic’s previous study (33.1%)(1).
In this study, among the patients who underwent primary penetrating keratoplasty due to CCO, 76.9% had
Peters anomaly, followed by 7.7% with glaucoma and
7.7% with sclerocornea. Central corneal opacity was the
most common finding with a rate of 78.1% in eyes with
Peters anomaly. The full thickness of the central corneal
pathology results in higher rates of penetrating keratoplasty in these patients as compared to other diseases.
In studies of pediatric penetrating keratoplasty, where
Peters anomaly was observed in majority of patients,
clear graft at the final visit was found in 29-75.1%(6-13).
Clear grafts were noted in 66.7% in the previous study
(mean follow-up time, 33.1 months) from our clinic(1)
and 76.0% at the last visit in this study (mean follow-up
time, 26.7 months). When analyzing 6 eyes with graft
failure, 4 had Peters anomaly (20 in total) and two had
sclerocornea (2 in total). The graft failure rate was 20%
in patients with Peters anomaly and 100% in those with
sclerocornea. Previous studies showed that graft fai
lure rates were also higher in sclerocornea as compared
to other CCO etiologies(1,13,14). While sclerocornea was
previously considered a separate and distinct diagnosis,
several pediatric ophthalmologists now consider it as an
(often severe) manifestation of various other conditions,
most commonly Peters anomaly and Axenfeld-Rieger
anomaly(15).
In this study, additional interventions during PK
were moderately positively correlated with graft failure.
In other studies in the literature, complicated cases
requiring additional interventions also had worse prognosis(9,12). Glaucoma was the most common pre- and
pos
toperative complicating factors(1,9,10,12). Glaucoma
history was also moderately positively correlated with
history of previous surgery before performing primary
ke
ratoplasty in this study. Since glaucoma control is
critically important for graft survival and to maintain
vision, the more eye surgeries performed, the poorer the
long-term prognosis is for the graft.
In conclusion, although Peters anomaly remains
the most common presenting etiology for CCO, its rate
appears to be increasing in the recent decade. CCO due
to birth trauma, which is one of the preventable causes,
1 02
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was observed in our clinic’s previous study; however,
no new cases were observed in this study. Although
idiopathic CCO was observed in our clinic’s previous
study, its rate appears to be decreasing in the recent
decade. Although CCO is rare in most clinical practice,
early diagnosis and management is deemed necessary to
decrease the risk of lifelong visual problems. However,
we believe that knowing the success rates of keratoplasty for CCO is also important so that patients and
their caregivers can be prepared to face this condition
by understanding the usual complications and possible
re-operations to realize their expectations about the final visual outcomes and their quality of life in the future.
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